Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ruanjianhugan is a **traditional Chinese medicinal herbal composition** formulated for the treatment of liver diseases—including viral hepatitis (HAV, HBV, HCV, HEV), alcoholic or fatty liver, and hepatocellular carcinoma[1]. It is typically formulated as a tablet and contains a combination of herbal ingredients, most notably **sophora root (Radix Sophorae Tonkinensis)**, **prunella (Spica Prunellae Vulgaris)**, **bushy knotweed root and rhizome (Radix et Rhizoma Polygonum)**, and other herbs. The proposed mechanisms of action are medicinal and hepatoprotective, potentially including anti-inflammatory and anti-viral effects, but explicit molecular targets are not documented in available sources. It is classified as a herbal multi-ingredient product and not a single active pharmaceutical compound. Its development is associated with traditional Chinese medicine approaches and is not tied to a single pharmaceutical company[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ruanjianhugan.